Lord Markham (Con)

I start by apologising because, due to a prior commitment, I am not able to stay for many of the proceedings today, but I see these groupings and others as critical. In the few words that I will say, I hope to bring to bear to this area some of my experience as a Health Minister, particularly in charge of technology and development of AI. I can see a lot of good intent behind these clauses, to make sure that we do not stop a lot of the research that we need. I was recently very much involved in the negotiation of the pandemic accord regarding the next pandemic and how you make sure that any vaccines that you develop on a worldwide basis can be distributed on a worldwide basis as well. One of the main stumbling blocks was that the so-called poorer countries were trying to demand, as part of that, the intellectual property to be able to develop the vaccines in their own countries. The point we were trying to make was that, although we could see the good intentions behind that, it would have a real chilling effect on pharmaceutical companies investing the hundreds of millions or even billions of pounds, which you often need with vaccines, to find a cure, because if they felt that they were going to lose their intellectual property and rights at the end, it would be much harder for them to justify the investment up front.